Insmed (NASDAQ:INSM) Price Target Raised to $83.00 at Bank of America
Insmed (NASDAQ:INSM – Get Free Report) had its price objective boosted by equities research analysts at Bank of America from $62.00 to $83.00 in a report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Bank of America‘s price target indicates a potential upside of 23.60% from […]
More Stories
Short Interest in Privia Health Group, Inc. (NASDAQ:PRVA) Grows By 19.8%
Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) was the recipient of a large increase in short interest in...
Deepwater Asset Management LLC Buys 10,186 Shares of Block, Inc. (NYSE:SQ)
Deepwater Asset Management LLC boosted its stake in shares of Block, Inc. (NYSE:SQ – Free Report) by 5.5% in the...
Phunware, Inc. (NASDAQ:PHUN) Short Interest Down 16.9% in June
Phunware, Inc. (NASDAQ:PHUN – Get Free Report) was the target of a significant decline in short interest during the month...
Bumble (NASDAQ:BMBL) Hits New 1-Year Low at $9.73
Bumble Inc. (NASDAQ:BMBL – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The...
Opera Limited (NASDAQ:OPRA) Sees Large Increase in Short Interest
Opera Limited (NASDAQ:OPRA – Get Free Report) was the recipient of a large growth in short interest in June. As...
Alpha Financial Markets Consulting (LON:AFM) Reaches New 1-Year High at $498.00
Alpha Financial Markets Consulting plc (LON:AFM – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday...